SKI Market

Indian Indices

Sensex

80,015.90 899.71
( 1.14%)

Global Indices

Nasdaq

48,766.17 243.89
(0.50%)

Dow Jones

6,891.51 53.88
(0.79%)

Hang Seng

55,141.42 895.88
(1.65%)

Nikkei 225

10,568.52 84.39
(0.80%)

Forex

USD-INR

91.96 0.48
(0.52%)

EUR-INR

106.94 -0.34
(-0.32%)

GBP-INR

122.70 0.09
(0.07%)

JPY-INR

0.58 0.00
(0.18%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hikal Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524735

INE475B01022

96.8412723

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HIKAL

91.5

2290.31

EPS(TTM)

Face Value()

Div & Yield %

2.03

0.43

Back

Bliss GVS Pharma consolidated net profit rises 12.32% in the September 2025 quarter

Nov 07,2025

Net profit of Bliss GVS Pharma rose 12.32% to Rs 27.25 crore in the quarter ended September 2025 as against Rs 24.26 crore during the previous quarter ended September 2024. Sales rose 12.27% to Rs 244.40 crore in the quarter ended September 2025 as against Rs 217.68 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	244.40	217.68	12
OPM %	13.00	19.05	-
PBDT	48.89	42.69	15
PBT	40.63	35.71	14
NP	27.25	24.26	12

80,015.90 899.71 ( 1.14%)

48,766.17 243.89 (0.50%)

6,891.51 53.88 (0.79%)

55,141.42 895.88 (1.65%)

10,568.52 84.39 (0.80%)

91.96 0.48 (0.52%)

106.94 -0.34 (-0.32%)

122.70 0.09 (0.07%)

0.58 0.00 (0.18%)